QIAseq targeted NGS panels, powered by our proprietary QIAseq Enrichment Technology technology, are specifically designed to overcome the challenges you face when identifying relevant genomic variants in targeted DNA sequencing. They enable complete and uniform target coverage, even for complex GC-rich regions like CEBPA. Furthermore, they facilitate high-confidence variant calls while reducing false-negative rates, and maximize flow cell utilization for a lower sequencing cost per sample. With a variant detection sensitivity enhanced down to 0.5, the targeted sequencing panels reduce false-positive rates while enabling correction of PCR-induced errors. Unique dual indices (UDIs) reduce index hopping and read-misalignment, giving you confidence in your data interpretation.